Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members

P. B. Bitterman, S. I. Rennard, B. A. Keogh, M. D. Wewers, S. Adelberg, R. G. Crystal

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

We evaluated 17 clinically unaffected members of three families with an autosomal dominant form of idiopathic pulmonary fibrosis for evidence of alveolar inflammation. Each person in the study was examined by gallium-67 scanning for a general estimate of pulmonary inflammation, and by bronchoalveolar lavage for characterization of the types of recovered cells and their state of activation. Eight of the 17 subjects had evidence of alveolar inflammation on the lavage studies. Supporting data included increased numbers of neutrophils and activated macrophages that released one or more neutrophil chemoattractants, and growth factors for lung fibroblasts - findings similar to those observed in patients with overt idiopathic pulmonary fibrosis. Four of these eight also had a positive gallium scan; in all the other clinically unaffected subjects the scan was normal. During a follow-up two to four years in seven of the eight subjects who had evidence of inflammation, no clinical evidence of pulmonary fibrosis has appeared. These results indicate that alveolar inflammation occurs in approximately half the clinically unaffected family members at risk of inheriting autosomal dominant idiopathic pulmonary fibrosis. Whether these persons with evidence of pulmonary inflammation but no fibrosis will proceed to have clinically evident pulmonary fibrosis is not yet known.

Original languageEnglish (US)
Pages (from-to)1343-1347
Number of pages5
JournalNew England Journal of Medicine
Volume314
Issue number21
StatePublished - 1986
Externally publishedYes

Fingerprint

Idiopathic Pulmonary Fibrosis
Pneumonia
Inflammation
Gallium
Pulmonary Fibrosis
Neutrophils
Fibroblast Growth Factors
Therapeutic Irrigation
Chemotactic Factors
Bronchoalveolar Lavage
Fibrosis
Macrophages
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bitterman, P. B., Rennard, S. I., Keogh, B. A., Wewers, M. D., Adelberg, S., & Crystal, R. G. (1986). Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. New England Journal of Medicine, 314(21), 1343-1347.

Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. / Bitterman, P. B.; Rennard, S. I.; Keogh, B. A.; Wewers, M. D.; Adelberg, S.; Crystal, R. G.

In: New England Journal of Medicine, Vol. 314, No. 21, 1986, p. 1343-1347.

Research output: Contribution to journalArticle

Bitterman, PB, Rennard, SI, Keogh, BA, Wewers, MD, Adelberg, S & Crystal, RG 1986, 'Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members', New England Journal of Medicine, vol. 314, no. 21, pp. 1343-1347.
Bitterman PB, Rennard SI, Keogh BA, Wewers MD, Adelberg S, Crystal RG. Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. New England Journal of Medicine. 1986;314(21):1343-1347.
Bitterman, P. B. ; Rennard, S. I. ; Keogh, B. A. ; Wewers, M. D. ; Adelberg, S. ; Crystal, R. G. / Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. In: New England Journal of Medicine. 1986 ; Vol. 314, No. 21. pp. 1343-1347.
@article{c3e1fdde251c478496a5f195315d1736,
title = "Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members",
abstract = "We evaluated 17 clinically unaffected members of three families with an autosomal dominant form of idiopathic pulmonary fibrosis for evidence of alveolar inflammation. Each person in the study was examined by gallium-67 scanning for a general estimate of pulmonary inflammation, and by bronchoalveolar lavage for characterization of the types of recovered cells and their state of activation. Eight of the 17 subjects had evidence of alveolar inflammation on the lavage studies. Supporting data included increased numbers of neutrophils and activated macrophages that released one or more neutrophil chemoattractants, and growth factors for lung fibroblasts - findings similar to those observed in patients with overt idiopathic pulmonary fibrosis. Four of these eight also had a positive gallium scan; in all the other clinically unaffected subjects the scan was normal. During a follow-up two to four years in seven of the eight subjects who had evidence of inflammation, no clinical evidence of pulmonary fibrosis has appeared. These results indicate that alveolar inflammation occurs in approximately half the clinically unaffected family members at risk of inheriting autosomal dominant idiopathic pulmonary fibrosis. Whether these persons with evidence of pulmonary inflammation but no fibrosis will proceed to have clinically evident pulmonary fibrosis is not yet known.",
author = "Bitterman, {P. B.} and Rennard, {S. I.} and Keogh, {B. A.} and Wewers, {M. D.} and S. Adelberg and Crystal, {R. G.}",
year = "1986",
language = "English (US)",
volume = "314",
pages = "1343--1347",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "21",

}

TY - JOUR

T1 - Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members

AU - Bitterman, P. B.

AU - Rennard, S. I.

AU - Keogh, B. A.

AU - Wewers, M. D.

AU - Adelberg, S.

AU - Crystal, R. G.

PY - 1986

Y1 - 1986

N2 - We evaluated 17 clinically unaffected members of three families with an autosomal dominant form of idiopathic pulmonary fibrosis for evidence of alveolar inflammation. Each person in the study was examined by gallium-67 scanning for a general estimate of pulmonary inflammation, and by bronchoalveolar lavage for characterization of the types of recovered cells and their state of activation. Eight of the 17 subjects had evidence of alveolar inflammation on the lavage studies. Supporting data included increased numbers of neutrophils and activated macrophages that released one or more neutrophil chemoattractants, and growth factors for lung fibroblasts - findings similar to those observed in patients with overt idiopathic pulmonary fibrosis. Four of these eight also had a positive gallium scan; in all the other clinically unaffected subjects the scan was normal. During a follow-up two to four years in seven of the eight subjects who had evidence of inflammation, no clinical evidence of pulmonary fibrosis has appeared. These results indicate that alveolar inflammation occurs in approximately half the clinically unaffected family members at risk of inheriting autosomal dominant idiopathic pulmonary fibrosis. Whether these persons with evidence of pulmonary inflammation but no fibrosis will proceed to have clinically evident pulmonary fibrosis is not yet known.

AB - We evaluated 17 clinically unaffected members of three families with an autosomal dominant form of idiopathic pulmonary fibrosis for evidence of alveolar inflammation. Each person in the study was examined by gallium-67 scanning for a general estimate of pulmonary inflammation, and by bronchoalveolar lavage for characterization of the types of recovered cells and their state of activation. Eight of the 17 subjects had evidence of alveolar inflammation on the lavage studies. Supporting data included increased numbers of neutrophils and activated macrophages that released one or more neutrophil chemoattractants, and growth factors for lung fibroblasts - findings similar to those observed in patients with overt idiopathic pulmonary fibrosis. Four of these eight also had a positive gallium scan; in all the other clinically unaffected subjects the scan was normal. During a follow-up two to four years in seven of the eight subjects who had evidence of inflammation, no clinical evidence of pulmonary fibrosis has appeared. These results indicate that alveolar inflammation occurs in approximately half the clinically unaffected family members at risk of inheriting autosomal dominant idiopathic pulmonary fibrosis. Whether these persons with evidence of pulmonary inflammation but no fibrosis will proceed to have clinically evident pulmonary fibrosis is not yet known.

UR - http://www.scopus.com/inward/record.url?scp=0022593011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022593011&partnerID=8YFLogxK

M3 - Article

VL - 314

SP - 1343

EP - 1347

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 21

ER -